Aiming at cancer stem cells (CSCs), PRR11 knockdown reduced CSC-like phenotypes and tumorigenicity of ESCC cells in vitro and in vivo through Wnt/β-catenin signaling [15]. The gene discussed is PRR11; the disease is esophageal squamous cell carcinoma.